Formulation and Evaluation of Self Nano Emulsifying Drug Delivery System of Raloxifene Hydrochloride | Zendy

T. Gayathri | Zendy; M. Venkata Ramana | Zendy; N. Rama Rao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Formulation and Evaluation of Self Nano Emulsifying Drug Delivery System of Raloxifene Hydrochloride

Author(s) -

T. Gayathri,

M. Venkata Ramana,

N. Rama Rao

Publication year - 2021

Publication title -

journal of drug delivery and therapeutics

Language(s) - English

Resource type - Journals

ISSN - 2250-1177

DOI - 10.22270/jddt.v11i4.4857

Subject(s) - raloxifene , bioavailability , drug , chemistry , pharmacology , drug delivery , zeta potential , selective estrogen receptor modulator , chromatography , first pass effect , estrogen receptor , breast cancer , medicine , nanotechnology , materials science , nanoparticle , cancer , organic chemistry

Raloxifene hydrochloride (RLX) is a selective Estrogen-receptor modulator used to treat osteoporosis as well as breast and endometrial cancer prevention. The bioavailability of RLX is only 2% due to substantial pre-systemic clearance. The goal of this research was to customise and characterise RLX-loaded self-nanoemulsifying drug-delivery systems (SNEDDS) by using bioactive excipients that impact drug metabolism. The droplet size, zeta potential and drug content determination of optimized formulation (F-06) was found to be 147.5 nm, -28.8, 99.67% respectively. The drug release study from the nano formulation was studied in Phosphate buffer 6.8 for all the formulations F1,F2,F3,F4,F5,F6 and F7. The optimized formulation was found to be F6 Keywords: Raloxifene hydrochloride, nanoemulsion, SNEDDS

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research